Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S5 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer
  1. Home
  2. Publications
  3. Supplementary Figure S5 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

Supplementary Figure S5 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

Authors:
  • NDNan Ding
    Nan Ding
  • AYA-Bin You
    A-Bin You
  • HYHu Yang
    Hu Yang
  • GHGuo-Sheng Hu
    Guo-Sheng Hu
  • CLChun-Ping Lai
    Chun-Ping Lai
  • WLWen Liu
    Wen Liu
  • FYFeng Ye
    Feng Ye

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707008
Abstract
Figure S5: EP300 is lowly expressed in CRC tissues and positively correlated with RERE.
Keywords
  • EPIGENETICS
  • GASTROINTESTINAL CANCERS
  • COLORECTAL CANCER
  • IMMUNOLOGY
  • IMMUNOMODULATION
  • ONCOGENES & TUMOR SUPPRESSORS
  • TUMOR SUPPRESSOR GENES
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.